TESARO, Inc.
Overview
TESARO, Inc. is a biopharmaceutical company that focuses on developing and commercializing cancer therapeutics. It operates as a subsidiary of GlaxoSmithKline plc, which acquired it in 2019.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to TESARO, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.